Michael A Hamilton, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1520 S Liberty Dr, Bloomington, IN 47403 Phone: 812-676-4500 Fax: 812-676-4501 |
Ashlee M Warren, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2605 E Creeks Edge Dr, Bloomington, IN 47401 Phone: 812-355-2300 Fax: 812-355-2302 |
Mary Mahern, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 642 S Walker St, Bloomington, IN 47403 Phone: 812-331-9160 Fax: 812-336-0277 |
Dr. Karl D Steinke, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3657 S Sare Rd, Bloomington, IN 47401 Phone: 812-339-2547 Fax: 812-339-2798 |
Dr. Jeffrey Mark Moseman, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 N Jordan Ave, Bloomington, IN 47405 Phone: 812-855-1625 Fax: 812-855-4628 |
Beth Conrad Rupp, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 N Jordan Ave, Bloomington, IN 47405 Phone: 812-855-0093 |
Melissa A Hullinger, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 995 S Clarizz Blvd, Bloomington, IN 47401 Phone: 812-353-3060 Fax: 812-353-3070 |
News Archive
More than 300 employees of Bristol-Myers Squibb Canada will get the day off from their regular work today, but they won't be taking it easy. Instead, they will be joining company retirees and members of their own families in helping out at a variety of community and charitable organizations as part of the company's third annual BMS Community Action Day.
In today's headlines, reports on congressional efforts to extend a payroll tax break and other work Congress must do before the end of the year - including the Medicare doc fix.
A daily glass of orange juice can help prevent the recurrence of kidney stones better than other citrus fruit juices such as lemonade, researchers at UT Southwestern Medical Center have discovered.
Modern cancer therapies start in cells - researchers compare cancer samples to healthy cells to discover how cancer is genetically different, and use cell lines to test promising new drugs. However, a University of Colorado Cancer Center study published this week in the journal Gynecologic Oncology shows that due to a high rate of contamination, misidentification and redundancy in widely available cell lines, researchers may be drawing faulty conclusions.
Europe is set to embark on two bold, visionary projects. The projects aim to invest up to one billion euroover ten years to fuel revolutionary discoveries. The Future and Emerging Technologies Flagship (FET) programme picked two among six visions for frontier research.
› Verified 8 days ago